
Xenical contains as active substance orlistat. Approved indication is the treatment of obesity (BMI> 30 or BMI> 28 and other risk factors). The effect is exerted locally by inhibiting the lipases in the intestine, thereby reducing the degradation of triglycerides and decreasing the absorption of fat. Continue reading